Sociodemographic and clinicopathologic characterization of cervical cancers in northern Nigeria

Objective: To evaluate the sociodemographic and clinicopathological characteristics of patients with cervical cancer seen in a tertiary referral center in northern Nigeria. Materials and Methods: Between January 2002 and December 2004, 70 consecutive patients with histologically confirmed cervical cancer, with a median age of 48 years (range, 30-75 years), were interviewed on the basis of a structured pro forma. Results: Of these patents, 39 (56%) had had no formal education, and 36 (51 %) were unemployed housewives. Sixty (86%) had become sexually active before 17 years of age; 44 (63%) were in polygamous families, and 25 (36%) patients were in at least a second marriage. There was an average of 6.8 live births per patient. Vaginal bleeding was seen in all patients, and 55 (79%) had vaginal discharges; 50 (71%) had a bulky cervical mass, and 46 (66%) presented with at least Stage IIIA disease. Squamous cell carcinoma was the commonest histology. The three HIV-seropositive patients were young and had advanced disease. Conclusion: Sociodemographic factors, such as low socioeconomic level, early age at first sexual intercourse and multiple sexual partners, place women at high risk of developing cervical cancer in northern Nigeria. Late presentation with advanced disease predominates.

Cervical cancer; Sociodemographic factors; Epidemiology; Clinical features; Africa

[1] Jenkins D., Sherlaw-Johnson C., Gallivan S.: “Can papilloma virus testing be used to improve cervical cancer screening?”. Int. J. Cancer, 1996, 65, 768.

[2] Jamal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.L.: “Cancer statistics”. CA Cancer J. Clin., 2003, 53, 5.

[3] Muñoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M. et al.: “The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain”. Int. J. Cancer, 1992, 52, 743.

[4] Parkin D.M.: “Cancer in developing countries”. Cancer Surv., 1994, 19/20, 519.

[5] Schiffman M.H., Brinton L.A.: “The epidemiology of cervical carcinogenesis”. Cancer, 1995, 76, 1888.

[6] Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide”. J. Pathol., 1999, 189, 12.

[7] Thomas J.O., Herrero R., Omigbodun A.A., Ojemakinde K., Ajayi I.O., Fawole A. et al.: “Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study”. Br. J. Cancer, 2004, 90, 638.

[8] Fonn S., Bloch B., Mabina M., Carpenter S., Cronje H., Maise C. et al.: “Prevalence of pre-cancerous lesions and cervical cancer in South Africa - a multicentre study”. S. Afr. Med. J., 2002, 92, 148.

[9] La Ruche G., Ramon R., Mensah-Ado I., Bergeron C., Diomandé M., Sylla-Koko F. et al.: “Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa”. Dyscer-CI Group. Cancer, 1998, 15, 2401.

[10] Ferlay J., Bray F., Pisani P., Parkin D.M.: “GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0 Lyon: IARC Press 2001, 5.

[11] Vizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros-Dios X.M., Parkin D.M. et al.: “International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas”. Int. J. Cancer, 1998, 75, 536.

[12] Brinton L.A., Hamman R.F., Huggins G.R., Lehman H.F., Levine R.S., Mallin K. et al.: “Sexual and reproductive risk factors for invasive squamous cell cervical cancer”. J. Natl. Cancer Inst., 1987, 79, 23.

[13] Winkelstein W.: “Smoking and cervical cancer: current status-a review”. Am. J. Epidemiol., 1990, 131, 945.

[14] Castellsague X., Bosch F.X., Muñoz N., Meijer C.J.L.M., Shah K.V., de Sanjosé S. et al.: “Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners”. N. Engl. J. Med., 2002, 346, 1105.

[15] Meanwell C.A.: “The epidemiology and etiology of cervical cancer”. In: Blackledge G.R.P., Jordan J.A., Shingleton H.M. (eds.). Textbook of Gynecologic Oncology. Philadelphia: WB Saunders, 1991, 250.

[16] Kostopoulou E., Keating J.T., Crum C.P.: “Pathology”. In: Eifel P.J., Levenback C. (eds.). Cancer of the Female Lower Genital Tract. London: BC Decker, Inc., 2001, 9.

[17] Robert M.E., Fu Y.S.: “Squamous cell carcinoma of the uterine cervix: a review with emphasis on prognostic factors and unusual variants”. Semin. Diagn. Pathol., 1990, 7, 173.

[18] Gates A.E., Kaplan L.D.: “AIDS malignancies in the era of highly active antiretroviral therapy”. Oncology (Huntingt) 2002, 16, 441.

[19] Castellsague X., Muñoz N.: “Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking”. Natl. Cancer Inst. Monogr., 2003, 31, 20.

[20] Koutsky L., Harper D.: “Current findings from prophylactic HPV vaccine trials”. Vaccine, 2006, 24S3, S3/114.